Regular Article
No Association of 6-Sulfatoxymelatonin with in-Bed 60-Hz Magnetic Field Exposure or Illumination Level among Older Adults

https://doi.org/10.1006/enrs.2002.4370Get rights and content

Abstract

We examined the association of 6-sulfatoxymelatonin (aMT6s) excretion with in-bed 60-Hz magnetic field (MF) exposure and other potential regulators. Adults aged 50–81 years (n=242 years, mean 67.6±5.7 years) were monitored for 1 week in their home environments. Mean and maximum MF exposure were assessed with EMDEX Lite instruments. Illumination mesor, amplitude, and acrophase (peak time) were determined from 24-h Actillume wrist monitors. Other regulators of aMT6s assessed were age, usage of melatonin-altering medications, and day length. During two 24-h intervals, all urine voidings were collected. The mesor, amplitude, and acrophase of aMT6s excretion were determined. Multiple regression analyses revealed no association between MF and aMT6s. Medication usage was associated with significantly lower aMT6s mesor and amplitude. Illumination acrophase and amplitude were significantly associated with aMT6s acrophase. These data suggest no influence of nocturnal environmental MF exposure on aMT6s excretion in older adults.

References (56)

  • P.J. Murphy et al.

    Nonsteroidal anti-inflammatory drugs alter body temperature and suppress melatonin in humans

    Physiol. Behav.

    (1996)
  • R.J. Reiter

    Alterations of the circadian melatonin rhythm by the electromagnetic spectrum: A study in environmental toxicology

    Regul. Toxicol. Pharmacol.

    (1992)
  • B. Selmaoui et al.

    Magnetic fields and pineal function in humans: Evaluation of nocturnal acute exposure to extremely low frequency magnetic fields on serum melatonin and urinary 6-sulfatoxymelatonin circadian rhythms

    Life Sci.

    (1996)
  • L. Wetterberg et al.

    The influence of age, sex, height, weight, urine volume and latitude on melatonin concentrations in urine multinational study

  • T. Akerstedt et al.

    A 50-Hz electromagnetic field impairs sleep

    J. Sleep Res.

    (1999)
  • M. Aldous et al.

    Radioimmunoassay of 6-sulphatoxy melatonin using an iodinated tracer

    Ann. Clin. Biochem.

    (1988)
  • J. Beck-Friis et al.

    Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome

    Acta Psychiatr. Scand.

    (1985)
  • D.E. Blask et al.

    Effects of melatonin on cancer: Studies on MCF-7 human breast cells in culture

    J. Neural Transm.

    (1986)
  • G.C. Brainard et al.

    The biological and behavioral effects of light in humans: From basic physiology to application

  • G.C. Brainard et al.

    The relationship between electromagnetic field and light exposures to melatonin and breast cancer risk: A review of the relevant literature

    J. Pineal Res.

    (1999)
  • K. Brismar et al.

    Melatonin secretion related to side-effects of beta-blockers from the central nervous system

    Acta Med. Scand.

    (1988)
  • J.B. Burch et al.

    Melatonin metabolite levels in workers exposed to 60-Hz magnetic fields: Work in substations and with 3-phase conductors

    J. Occup. Environ. Med.

    (2000)
  • J.B. Burch et al.

    Nocturnal excretion of a urinary melatonin metabolite among electric utility workers

    Scand. J. Work Environ. Health

    (1998)
  • J.B. Burch et al.

    Reduced excretion of a melatonin metabolite in workers exposed to 60Hz magnetic fields

    Am. J. Epidemiol.

    (1999)
  • M. Cohen et al.

    Melatonin/Progestin OC's: A method to prevent breast cancer?

    (1992)
  • S. Davis et al.

    Residential magnetic fields, light-at-night, and nocturnal urinary 6-sulphatoxymelatonin concentration in women

    Am. J. Epidemiol.

    (2001)
  • S. Davis et al.

    Night shift work, light at night, and risk of breast cancer

    J. Nation. Cancer Inst.

    (2001)

    • Cited by (0)

    View full text
    Copyright © 2002 Elsevier Science (USA). All rights reserved.